1.70000 EUR
0.09
5.03%
Last update Dec 15, 3:29 PM CET
Market closed
Day range
1.69000
1.70000
Previous close
1.79000
Open
1.69000
Access this stock data via API
Subscribe
NRX Pharmaceuticals Inc.
1.70
0.09
5.03%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 206.1K 0 0 0
Cost of revenue 82.6K
Gross profit 123.5K
Operating expense
Research & development 1.2M 840.7K 684.8K 882.4K
Selling general and admin 2.4M 2.3M 2.5M 2.2M
Other operating expenses -80.1K
Operating income -3.4M -3.2M -3.2M -2.1M
Non operating interest income
Income 1.7K 1.7K 3.4K 3.4K
Expense 0 0 0 0
Other income expense -1.6M -11.8M -1.5M -5.7M
Pretax income -5.0M -15.0M -4.7M -7.7M
Tax provision
Net income -5.0M -15.0M -4.7M -7.7M
Basic EPS -0.3 -1.0 -0.3
Diluted EPS -0.3 -1.0 -0.3
Basic average shares 18.9M 15.3M 14.0M
Diluted average shares 18.9M 15.3M 14.0M
EBITDA -4.7M -9.5M -6.0M -6.3M
Net income from continuing op. -5.0M -15.0M -4.7M -7.7M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 5 hours 9 minutes

02:50
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).